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ARTICLE OPEN
“A palliative end-stage COPD patient does not exist”: a
qualitative study of barriers to and facilitators for early
integration of palliative home care for end-stage COPD
Charlotte Scheerens1,2, Luc Deliens1,2, Simon Van Belle1,4, Guy Joos2,5, Peter Pype1,3 and Kenneth Chambaere1,2
Early integration of palliative home care (PHC) might positively affect people with chronic obstructive pulmonary disease (COPD).
However, PHC as a holistic approach is not well integrated in clinical practice at the end-stage COPD. General practitioners (GPs)
and community nurses (CNs) are highly involved in primary and home care and could provide valuable perspectives about barriers
to and facilitators for early integrated PHC in end-stage COPD. Three focus groups were organised with GPs (n= 28) and four with
CNs (n= 28), transcribed verbatim and comparatively analysed. Barriers were related to the unpredictability of COPD, a lack of
disease insight and resistance towards care of the patient, lack of cooperation and experience with PHC for professional caregivers,
lack of education about early integrated PHC, insufﬁcient continuity of care from hospital to home, and lack of communication
about PHC between professional caregivers and with end-stage COPD patients. Facilitators were the use of trigger moments for
early integrating PHC, such as after a hospital admission or when an end-stage COPD patient becomes oxygen-dependent or
housebound, positive attitudes towards PHC in informal caregivers, more focus on early integration of PHC in professional
caregivers’ education, implementing advance care planning in healthcare and PHC systems, and enhancing communication about
care and PHC. The results provide insights for clinical practice and the development of key components for successful practice in a
phase 0–2 Early Integration of PHC for end-stage COPD (EPIC) trial, such as improving care integration, patients’ disease insight and
training PHC nurses in care for end-stage COPD.
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BACKGROUND
Chronic obstructive pulmonary disease (COPD) is one of the
leading causes of death,1 with an illness trajectory characterised
by a progressive and inexorable decline interlaced with acute
exacerbations.2 People with end-stage COPD (which we chose to
deﬁne as ‘mostly GOLD stage III or IV3 and low to very low
functioning’, although no clear deﬁnition of severe, very severe or
end-stage COPD is available in literature), mainly suffer from
symptoms such as dyspnea, pain, fatigue, anxiety and low mood,
leading to a poor quality of life in the ﬁnal stages of the disease.4
Despite numerous therapies to treat symptoms, end-stage COPD
impacts heavily on emotional and social functioning and daily
activities.4 Their physical and psychosocial symptoms are poorly
addressed.5
We know from former research that palliative care (PC), if
integrated earlier than the ﬁnal weeks of life with standard care,
can offer support for these symptoms as they in fact signal PC
needs, and may have a positive impact on people with end-stage
COPD.6,7 The Global initiative for chronic Obstructive Lung Disease
(GOLD) also recommends early intergrated PC as a way to improve
symptoms that reﬂect PC needs (such as dyspnea, anxiety, pain,
and fatigue), which would potentially be better treated if PC was
not only introduced in end-of-life situations.3
However, there is no unifying deﬁnition or common under-
standing in literature of early integrated PC. This might be due to
the polymorphous nature of integrated care itself.8 For this study,
the meaning of early integrated PC can be derived from
combining deﬁnitions of PC and Integrated Health Services given
by the World Health Organization (WHO). The WHO deﬁnition of
PC incorporates: (1) encouraged collaboration between all
professional caregivers (which we deﬁne as general practitioners,
specialist physicians, nurses, physiotherapists, dentists, pharma-
cists, midwives, and paramedics), in order to connect expertize;
and (2) early assessment of PC, by integrating PC with disease
based “curative” therapies.9 Furthermore, the WHO deﬁnition of
Integrated Health Services emphasises on “the management and
delivery of health services so that patients receive a continuum of
preventive and curative services, according to their needs over
time and across different levels of the health system.”10
Moreover, patients with end-stage COPD often die in intensive
care units in hospitals or nursing homes rather than at home,11
whereas end-stage COPD patients actually prefer home care,12
and patients with all kinds of diseases wish to die at home.13 If PC
is provided at home by a PC nurse or PC professional, it can also
improve quality of life and care,14,15 increase the chance of dying
at home16 and reduce the burden of symptoms.17 Moreover, early
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integrated palliative home care (PHC) can help to avoid hospital
admissions and escalation of costs related to the ﬁnal months of
life for people with end-stage diseases.18 Lastly, a qualitative study
has shown that end-stage COPD patients have indicated needs for
PHC and fully accept early integrated PHC.19
Early integrated PHC for end-stage COPD patients in practice,
however, is not without its challenges as the unpredictable illness
trajectory and chance of survival can interfere with its early
integration.6
In Belgium, COPD accounted for 10.7% of all deaths, which
made it the third most common cause of death in 2015.20
Furthermore, a study in Flanders revealed that of all deaths from
end-stage COPD in 2013, only 37.3% were referred to PC, of which
7.2% to PHC. For half of the referred patients, time of onset of PC
was only six days prior to death.21 Reasons for not referring end-
stage COPD patients were according to the physicians due to a
lack of time, because PC was not meaningful, or that PC needs
were addressed in standard care.21 As research on implementing
early integration of PHC for end-stage COPD is thin on the ground,
with studies only exploring patients’ acceptance of integrated
PHC,19 investigating PC and end-of-life discussions for COPD in
general22 or not speciﬁcally focusing on end-stage COPD,16,23 a
more detailed examination of challenges and possibilities for early
integration of PHC for end-stage COPD is needed to gain insight
into reasons why early integration of PHC for end-stage COPD is
currently lacking and how to tackle this.
Likewise, little is known about the opinions of involved parties
in early integrating PHC for end-stage COPD, with the exception of
patients' perspectives19 as well as those of pulmonologists.24
However, the views of general practitioners (GPs) and community
nurses (CNs) on early integrated PHC for end-stage COPD are
lacking. These perspectives are crucial in identifying speciﬁc
reasons why implementing this type of care is difﬁcult in end-
stage COPD25,26 as GPs and CNs in Belgium are active in primary
and home care and well informed about PHC services. In order to
gain useful data for clinical and policy-related solutions, this study
aims to identify (1) barriers and (2) facilitators from the perspective
of GPs and CNs for early integration of PHC in standard care for
people with end-stage COPD. This qualitative study is performed
as a part of a larger study to develop a complex phase 0–2
intervention trial on early integrated PHC for end-stage COPD
(EPIC) in Flanders, Belgium.
RESULTS
Participant characteristics (Table 1)
Three focus group interviews with GPs and four with CNs were
held with a total of 28 GPs (n= 8, n= 10, n= 10) and 28 CNs (n=
4, n= 7, n= 5, n= 12) that attended one of seven focus groups.
The majority of participants were between 40 and 60 years old,
and 32 were male. Clinical working experience was variable, with
the largest groups (each seventeen participants) working for zero
to nine years and working for 20–29 years. 32 of 56 participants
did not introduce PC to end-stage COPD patients in the past year.
As we recruited GPs through local peer review groups and CNs
through area-speciﬁc group meetings for six of the seven focus
group conversations, not all participants of these focus groups
met the predeﬁned inclusion criteria: 11 of 56 participants did not
have ﬁve years or more clinical working experience, and nine
participants did not care for at least three end-stage COPD
patients in the last year. We also found out during the focus
groups that ten participants were member of a PHC team as a PHC
physician or PHC nurse, either currently or in the past, without our
prior knowledge.
Barriers to early integration of PHC for end-stage COPD (Table 2)
Disease trajectory of end-stage COPD. Because of the unpredict-
able disease trajectory of end-stage COPD (1.a), people with end-
stage COPD often experience unexpected exacerbations or other
infections, and a sudden death. This made it difﬁcult to decide
when or whether PHC is needed. According to participants in
FG2gp and FG5cn, it was also unclear when to go from curative
care to PHC as the deteriorating functioning of the patient is often
invisible (1.b) to the professional caregiver as the disease evolves
slowly.
I once saw a terminal COPD patient, with heavy exacerbations,
as if he was almost gone, but he can now live further and
wrestle through all of that again. And I think that maybe that
has something to do with it, that we [professional caregivers]
don’t quite see it [deterioration] like that, right? (FG1, GP).
Perceived patient attitudes. A lack of disease-insight (2.a) was
mentioned, as some end-stage COPD patients did not seem to
understand cognitively the severity of end-stage COPD and the
possibility of death. This made it difﬁcult for professional
caregivers to start talking about PHC because the patient did
not grasp the need for it. Participants associated this attitude more
with their end-stage COPD patients than patients with other
diseases such as cancer. Denial of the severity of end-stage COPD
even when aware of the possible negative consequences was
another example of lacking disease insight:
You also have these [end-stage COPD] patients, we see that
visually, whose health is declining. Blue lips, blue as… They
rarely accept that when you tell them [that they are going to
die] - No, no… I am not going to die. That is the denial, that is
that denial (FG5, CN).
Resistance towards care (2.b) was also mentioned, an attitude
which depended on the patient’s personal context and personality.
For example, some patients did not want further help from
professional caregivers because they wanted to be left alone, while
others refused it because of the wish to live life the way they wanted,
thereby accepting the consequences. A participant explained that an
end-stage COPD patient kept on smoking even when severely ill,
stating it was too late for help anyhow. Other patients seemed to
wait too long to contact a doctor, which made early integration of
PHC impossible as they died before care could be given.
But, information… there are many who do not want to hear it
[information about further care possibilities such as palliative
home care], they [the patient] tell us [professional caregivers]
to leave them alone (FG7, CN).
Finally, participants mentioned that the attitude towards PHC
was one of resistance because of the perceived afﬁliation with
death (2.c), as seen in this quotation:
We [professional caregivers] try to stimulate that [palliative
home care] for our [end-stage COPD] patients, but it is really
hard. Palliative care has a bad connotation, you know. When
patients hear they are palliative, they believe they are going to
die (FG5, CN).
Professional caregiver practices. The lack of a coherent and
proactive care plan (3.a) in professional caregiver practices formed
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a barrier, ﬁrstly because professional caregivers experienced care
coordination problems in the home situation of patients with end-
stage COPD. For example:
On improving care: you have the cleaning help, the family help,
the nurses and so on, and they all have something to say about
the [end-stage COPD] patient, like maybe you should try this or
that sometime, maybe try that again, and then you, the general
practitioner, arrives there, and there you are, with your
scientiﬁc background and all the scientiﬁc evidence that you
have learned, and all of those suggestions are ﬁred at and you
have to say “yeah, but that will not help, and that will not help
either, and I sometimes ﬁnd it difﬁcult, that everyone
[professional caregivers] has their opinion (FG1, GP).
Secondly, conﬂicting therapies between professional caregivers
were said to prevent the early integration of PHC as well:
To me, a good general practitioner is someone who does
nothing. He only manages and says “I think you are suffering
from that illness, you should go see that specialist physician.” I
think that is great. Because they cannot know everything, I fully
Table 1. Characteristics of participating general practitioners and community nurses (n= 56)
General practitioners Community nurses Total
Characteristics FG1 (n= 8) FG2 (n= 10) FG3 (n= 10) FG4 (n= 4) FG5 (n= 7) FG6 (n= 5) FG7 (n= 12) 56
Sex
Male 4 4 4 2 3 4 3 24
Female 4 6 6 2 4 1 9 32
Age
≤29 1 1 3 2 7
30–39 1 2 2 2 2 9
40–49 1 4 1 4 1 1 4 16
50–59 4 1 1 1 4 4 15
60–69 1 2 6 9
≥70
Practice location
Urban 8 10 4 2 24
Semi-urban or rural 10 7 3 12 32
Number of end-stage COPD
patients cared for in the last year
(1 non-response) (1 non-response)
None 4 1 1 3 9
1–9 1 3 1 2 9 16
10–19 4 1 1 5 2 13
20–29 1 1 4 1 7
≥30 2 7 9
Number of end-stage COPD patients introduced to palliative care in the last year
None 5 2 7 1 4 2 11 32
1–3 2 8 3 3 2 18
4–6 1 3 1 5
7–9
≥9 1 1
Active in a palliative home care team
Yes 4a 3a 2b 1b 10
No 8 6 7 2 6 5 12 46
Clinical work experience (years)
0–4 1 2 1 4 3 11
5–9 1 1 0 1 3 6
10–19 1 2 2 2 1 3 11
20–29 3 3 2 2 2 2 3 17
≥30 2 2 5 2 11
aGeneral practitioners were recruited as members of a LOK group. Without our prior knowledge, we found out they were part of a palliative home care team as
palliative care physicians
bCommunity nurses were recruited solely because of their experience as a community nurse. Without our prior knowledge, some of them have had experience
as a palliative home care nurse in the past or as a second job. One participant was recruited in FG4 because another participant canceled. This participant was
a palliative home care nurse in the past, but is currently a full-time researcher on palliative care
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agree. But, too often, you see general practitioners who think
they have the answer, while they are totally wrong and that
gives complications when it comes to patient compliance. Like
when you [and end-stage COPD patient] show up with a
specialist’s advice and your general practitioner says “hmm, you
should not do that”. Come on, that cannot happen (FG5, CN).
Next, insufﬁcient experience with and a negative vision of
PHC for end-stage COPD (3.b) was noted during the focus
groups as PHC in itself was either not well known or its
usefulness for end-stage COPD was not clear to participants due
to a lack of experience in PC for this particular patient group.
During the focus groups, participants often claimed that ‘a
palliative end-stage COPD patient does not exist’. Others asked
the moderator to explain what PHC could do for people with
end-stage COPD:
The reason I would not immediately use PHC is that I need to
know what they can offer in that context. So we want them to
be able to offer comfort at a critical moment. But what can they
do for someone who is suffocating? So then we need to
hospitalize them after all (FG2, GP).
Related to this, professional caregivers did not clearly see the
added value of early integrated PHC for end-stage COPD as PC is
perceived to curtail all curative options for the patient. Stopping
curative care and starting PHC was said to feel unnatural,
especially for GPs, as they want to cure the patient.
Education for professional caregivers. Basic and continuing
education about PHC and its advantages for end-stage COPD
seemed to be lacking, which also inﬂuenced the barriers about
professional caregiver practices:
Table 2. Barriers according to general practitioners (GPs) (FG1gp, FG2gp, and FG3gp) and community nurses (CNs) (FG4cn, FG5cn, FG6cn, and FG7cn) for
early integrating palliative home care in standard care for patients with end-stage COPD
1 Disease trajectory of COPD 1.a: Unpredictable exacerbations and death (FG1gp, FG2gp, FG3gp,FG5cn, FG7cn)
1.b: Invisible deterioration of functioning (FG2gp, FG5cn)
2 Perceived patient attitudes 2.a: Lack of disease insight:
1. Not understanding the severity of the disease or realizing the possibility of death (FG1gp,
FG2gp, FG3gp, FG5cn, FG7cn)
2. Denial of the severity of the disease (FG2gp, FG5cn)
2.b: Resistance to care
1. The wish to be left on their own (FG2gp, FG5cn, FG6cn, FG7cn)
2. The wish to lead the life as they wished, accepting the consequences (FG1gp, FG3gp, FG5cn,
FG7cn)
2.c: Resistance towards palliative (home) care because of the association with death (FG2gp,
FG3gp, FG6cn, FG7cn)
3 Professional caregiver practices 3.a: Lack of a coherent and proactive care plan
1. No cooperation between professional caregivers involved in home care (FG1gp, FG4cn, and
FG7cn)
2. Conﬂicting therapy and treatment between professional caregivers (FG3gp, FG5cn)
3.b: Insufﬁcient experience with and negative vision of palliative home care for end-stage COPD
1. No experience in clinical practice with palliative (home) care for end-stage COPD (FG1gp,
FG2gp, FG3gp, FG5cn, and FG7cn)
2. Professional caregivers continue to give life-prolonging care as added value of palliative
(home) care for people with end-stage COPD is not clear (FG1gp, FG5cn)
4 Education for professional caregivers Not enough focus on knowledge and advantages of palliative (home) care for end-stage COPD in
professional caregivers’ basic and continuing education (FG2gp, FG3gp, FG5cn, and FG6cn)
5 Healthcare and palliative home care system
characteristics
5.a: Consultations: not enough time during consultations to start talking about palliative home
care and further care (FG4cn)
5.b: Coordination between hospital and home care
1. Lack of guidance on how to early integrate palliative home care to allow the patient to stay
and die at home (FG1gp, FG2gp, and FG6cn)
2. Discharge from hospital to home situation without concrete guidelines (FG1gp, FG3gp)
5.c: Reimbursement system for palliative home care services
1. Palliative status for palliative home care is based on predictability of death (FG2gp, FG5cn)
2. Palliative reimbursement of palliative home care is restricted to 3 months (FG2gp, FG3gp, and
FG7cn)
6 Communication 6.a: Inter-professional communication
1. Not knowing each other well enough for proper communication (FG2gp, FG3gp, FG5cn, and
FG6cn)
2. Unclear who takes initiative to introduce palliative home care to end-stage COPD patients
(FG3gp)
3. Not understanding each others' messages (FG2gp)
6.b: Communication between caregiver and end-stage COPD patient
1. Not discussing palliative care (needs) in detail during consultations with end-stage COPD
patients (FG2gp)
2. Difﬁculties for professional caregivers to talk about palliative care needs with their end-stage
COPD patients (FG2gp, FG3gp, and FG4cn)
3. Patient–family relationship can prevent communication on palliative home care (FG1gp,
FG5cn, and FG7cn)
4. Professional caregivers fear talking about palliative home care because of the patient’s
reaction (FG5cn)
A palliative end-stage COPD patient does not exist
C Scheerens et al.
4
npj Primary Care Respiratory Medicine (2018)  23 Published in partnership with Primary Care Respiratory Society UK
I wonder, if we, as general practitioners, would be better
educated and could prescribe oxygen, how we could quickly
move on to be giving oxygen. I think that would prevent a lot
of hospitalizations (FG3, GP).
Healthcare and PHC system characteristics. Timeslots for profes-
sional caregivers’ consultations which are too short (5.a), due to
the fact that professional caregivers are paid per consultation,
prevented discussions about early integrated P(H)C as this topic
requires a lot of time to explain properly. Furthermore, coordina-
tion between hospital and home care (5.b) was inefﬁcient,
observed in a lack of guidance on how to early integrate PHC
into the home situation of an end-stage COPD patient in order to
keep the patient at home until death. Also, a lack of concrete
guidance after discharge from hospital to home was mentioned,
with end-stage COPD patients sometimes leaving the hospital
without knowing what the next steps of care are:
I [general practitioner] never knew anything [of information
given by someone] from the hospital for COPD (FG2, GP).
Simply said: ‘go home and handle it [the situation where the
end-stage COPD patient is in] yourself (FG2, GP).
The reimbursement system for PHC (5.c) in Flanders is by law
restricted to three months, with the possibility of making a second
claim,27 which can be interpreted as an existing structural barrier
for referring patients to PHC. To receive this reimbursement, a
patient needs to have a legal palliative status, which depends on
life expectancy, i.e., between three months and 24 h before death
(this rule was still legal at the time of the focus groups). As the
unpredictable disease trajectory of end-stage COPD makes it hard
to predict whether a patient is in the ﬁnal three months of life, this
was also for the participants seen as a barrier. Although early
integrated PHC can be provided if patients do not have this status,
and costs related to PHC are reimbursed even if patients are still
alive after three months, GPs and CNs saw this restriction of three
months as a psychological obstacle to early integrating PHC:
Three months, right, if you want to request palliative care for
three or six months, we do not know whether that will be the
case [for a end-stage COPD patient], and that keeps you from
proposing this [palliative home care] to the patient, because of
that palliative status (FG3, GP).
Communication. A lack of proper communication between the
involved professional caregivers (6.a GP), pulmonologist, CNs and
PHC nurses) was observed due to different roles and perspectives
on care:
Specialists also speak from an ivory tower. I’m thinking of a
woman [with end-stage COPD] now, who is terminal, and sure,
she has a lot of pain and she uses tramadol [an opioid]. Step
one in the treatment, according to them [pulmonologists], is
medication because it suppresses the respiratory system. But,
come on. That is easy to say behind your little desk, wearing
your suit, is it not? (FG2, GP)
There was also confusion about who should take the initiative
to early integrate PHC for the patient, along with miscommunica-
tions in referral letters, cited by this quote:
Referral letters mentioning no possibilities for curative treat-
ment for a cancer patient [from oncologists to general
practitioners] often state: “referral to palliative team”. But with
terminal COPD it [the referral letter from pulmonologists] just
says “lung function borders livability”. (FG2, GP).
Another barrier was communication between professional
caregivers and patients with end-stage COPD (6.b), as talking
about further care and PHC needs with the patient was mentioned
to be difﬁcult during consultations, especially when patients’
Table 3. Facilitators according to general practitioners (GPs) (FG1gp, FG2gp, and FG3gp) and community nurses (CNs) (FG4cn, FG5cn, FG6cn, and FG7cn)
for early integrating palliative home care in standard care for patients with end-stage COPD
1 Trigger moments 1.a: Hospital admission
1. After hospital admission, a moment to start talking about the future (FG1gp, FG2gp, FG3gp,
FG4cn, FG6cn)
2. After hospital admission, a moment to reorganize care (FG2gp)
1.b After a couple of exacerbations (FG2gp)
1.c: When an end-stage COPD patient becomes oxygen-dependent (FG2gp, FG3gp)
1.d: When an end-stage COPD patient is confronted with loss of functioning and becomes
housebound (FG1 gp, FG2gp, FG5cn)
2 Involvement of informal caregivers Increase knowledge about advantages of palliative home care for informal caregivers from
patients with end-stage COPD (FG1gp, FG2gp, FG3gp, FG5cn)
3 Education for professional caregivers More focus on early integrated palliative home care for end-stage COPD and concrete
implementation in clinical practice in education for professional caregivers (FG5cn)
4 Healthcare and palliative home care system
characteristics
Start advance care planning as a standard procedure for end-stage COPD patients living at home
(FG1gp, FG2gp, FG3gp, FG4cn, FG7cn)
5 Communication 5.a: Communication between professional caregivers and end-stage COPD patients
1. Talking about practical matters can help professional caregivers to start talking about
palliative home care (FG2gp, FG3gp)
2. Inform end-stage COPD patients clearly and ﬁrmly about their disease and future (FG4cn)
3. Better explanation of the term early integrated palliative home care can help acceptance for
end-stage COPD patients: talk about it as comfort care, psychosocial support (FG2gp)
5.b: Communication between professional caregivers: appoint a care coordinator who facilitates
the care transition to early integrated palliative home care (FG3gp, FG5cn, FG6cn)
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family members were involved.
If his wife is not at home, then he [end-stage COPD patient] is
incredibly chatty and he can pour out his heart: “and I do not
want to live anymore and I want to die.” And when his wife
gets back, the ﬁrst thing he says: “do not say anything, my wife
is here”. But come on, we only get to talk to him for ﬁfteen
minutes and the rest of the day he is with her. You realize he
cannot discuss his illness with her, right? (FG5, CN).
Lastly, all focus groups mentioned communication problems
due to the terminology of PHC, stating that the term has negative
connotations for end-stage COPD patients and professional
caregivers, as it implies impending death.
Facilitators for early integration of PHC for end-stage COPD (Table
3)
Trigger moments. Participants expressed the need for trigger
moments in the course of the disease trajectory of end-stage
COPD as a way to facilitate early integration of PHC. Examples
were after a hospital admission (1.a) as a moment to start talking
about the future or reorganising care, a couple of exacerbations (1.
b), when the patient becomes oxygen-dependent (1.c) or house-
bound due to a loss of functioning (1.d). These moments were
seen as turning points when the patient realises the severity of the
disease more clearly:
Someone [end-stage COPD] who goes home after hospital and
gets oxygen, that is an important thing to work on as a team
[of professional caregivers]. And that [early integrated PHC] is
something we [professional caregivers] could then discuss
(FG2, GP).
For example, I think that starting oxygen at home is quite the
occasion [for early integrating PHC]. After all, it announces a
huge phase (FG2, GP).
Involvement of informal caregivers. Mainly GPs thought that
providing more information about PHC and increasing positive
attitudes towards it among informal caregivers (such as family
members, volunteers of PHC teams) could encourage the latter to
support the end-stage COPD patient with early integrated PHC:
We [general practitioners] are often asked by the family to
come and talk without the patient being present. And then we
discuss what will happen, what the palliative home care team
could do, practical agreements (FG2, GP).
Education for professional caregivers. When talking about knowl-
edge and care for end-stage COPD, there was an urgent need for
more information about early integrated PHC for end-stage COPD
and clinical implementation of it given in standard and further
education of professional caregivers. This could better prepare
professional caregivers in supporting end-stage COPD patients.
Healthcare and PHC system characteristics. Advance care planning
(ACP) as a standard procedure in clinical practice for all end-stage
COPD patients could facilitate conversations about the future,
further wishes and needs. This could trigger professional caregivers
and COPD after end-stage patients to think about integrating PHC
earlier. ACP is already a practice in nursing homes in Belgium:
Because at that moment [going to a nursing home] there is a
very important changeover in the life stage of a person. And
because it is actually common to do advance care planning for
someone who ends up in a nursing home. That is a procedure
(FG2, GP).
Reply: we should do this for all our chronic ill patients (FG2,
GP).
Communication. Enhancing communication from professional
caregivers towards end-stage COPD patients (5.a) could be a
facilitator, by using practical matters such as ‘where would you like
to die’ as a way to start talking about early integrated PHC.
Another possibility could be giving clear-cut information about
end-stage COPD and future chances of survival in order to make
the patient realise the severity of their disease:
You do not need that [advance directive] if you are already at
the point of dying. But for the things that might come. I think
about an end-stage COPD patient who always says that “they
[professional caregivers] will never put me on those machines
[in the hospital] anyway, right?”. [General practitioner says:]”-
Sure, but then we do really have to put that on paper, right?”
And that is where you have a lead [to start talking about early
integration of PHC]. Those practical questions are hints to talk
about how far you want to go [in future care] (FG2, GP).
Patients should be correctly informed about further possibi-
lities, about what medical care can still do for them. And then
the conversation should mainly be about what the patient still
wants and what he or she still expects and, and good
agreements will have to be made about what will and what will
no longer happen to the patient. And if hospitalization is out of
the question, how are we [professional caregivers, patient and
informal caregivers] going to organize the care package, and
especially, with what objective? (FG4, GP).
Furthermore, even if some respondents felt the need to change
the term PHC to supportive home care, others stated that focusing
on symptom management, comfort and psychosocial support in
conversations with end-stage COPD patients could also help the
latter to accept the content of P(H)C:
You do not have to use the term palliative if you can say okay,
from now on we will give you [end-stage COPD patient]
maximum comfort and we will do everything to take care of
you as good as possible without calling that directly palliative
[care] (FG2, GP.)
Finally, improving communication between professional care-
givers (5.b) by appointing a care coordinator to facilitate the
information ﬂow between professional caregivers involved in
hospital and home settings and integrating different professional
caregivers’ perspectives could increase early integration of PHC. If
specialist physician’s medical information would be combined
with information from home and primary caregivers this could
provide a better view of the patient’s personal, medical and social
context. A care coordinator could also introduce the advantages of
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early integrated PHC to the patient and their informal caregivers,
as this function could have more time for these conversations
than other currently involved professional caregivers:
Looking at each end-stage COPD patient to see which network
can be provided and making connections with specialists'
network. “Which nurse, which GP would you [the patient] like?”
Then every end-stage COPD patient will have their own
network up to informal care (FG5, CN).
DISCUSSION
Main ﬁndings
The results of this study have revealed perceived barriers and
facilitators from the perspective of general practitioners (GPs) and
community nurses (CNs) to early integration of palliative home
care (PHC) in standard care for people with end-stage COPD in
Flanders, Belgium. The categories of barriers were (1) unpredict-
able exacerbations and death in COPD and invisible deterioration
of functioning; (2) perceived patient attitudes such as a lack of
disease insight and resistance towards care; (3) professional
caregiver practices with a lack of a coherent and proactive plan,
insufﬁcient experience and a negative view of PHC for end-stage
COPD; (4) not enough focus on knowledge and advantages of PHC
and palliative care (PC) for end-stage COPD in professional
caregivers’ basic and continuing education; (5) healthcare and
PHC system characteristics: too short consultations, insufﬁcient
coordination between hospital and home care, and a reimburse-
ment system for PHC that is based on life expectancy; and (6)
communication: a lack of and unclear communication about care
possibilities for end-stage COPD patients between professional
caregivers, and a lack of clear information about PHC between
professional caregivers and their patients.
The categories of facilitators were (1) trigger moments to start
talking about early integration of PHC: such as after hospitalisa-
tion, after a couple of exacerbations, when an end-stage COPD
patient becomes oxygen-dependent or becomes housebound; (2)
involvement of informal caregivers in early integrated PHC for
COPD; (3) information about the advantages of early integrated
PHC for end-stage COPD in professional caregivers’ education; (4)
including advance care planning (ACP) as a part of healthcare and
PHC systems and (5) enhancing communication between profes-
sional caregivers by installing a care coordinator, and enhancing
communication between professional caregivers and end-stage
COPD patients by explaining better and giving practical examples
of what early integrated PHC could mean for end-stage COPD.
Interpretation of ﬁndings in relation to previous research
The following barriers were in line with previous research on
(communication about) PC in general, early integration of PHC or
PC for end-stage COPD: 1.a: unpredictable exacerbations and
death;6 3.b.2: continuation of life-prolonging care in end-stage
COPD;28 5.a: lack of time during consultations to start talking
about PHC and further care;28 5.b: no coordination between
hospital and home care;24 6.b.1: not discussing PHC, PC and PC
needs in detail during consultations;29 6.b.4: professional care-
givers’ fear of talking about PHC because of the patient’s
reaction.30
For facilitators we saw similarities with former studies on trigger
moments 1.a: after hospital admission,31 and 1.c: when an end-
stage COPD patient becomes oxygen-dependent;32 3) professional
caregivers’ education, with the importance of providing more
focus on (implementation of) early integrated PHC;24,33 4: health
system and PHC system characteristics with reported advantages
of ACP as a way to introduce PHC;24 5.a.2: enhancing
communication between professional caregivers and end-stage
COPD patients by better informing the latter about PHC
possibilities;24 5.b: improving communication between profes-
sional caregivers by appointing a care coordinator.24
Due to the speciﬁc focus on early integrated PHC for end-stage
COPD, this study also identiﬁed new insights into barriers on
conﬂicting therapies and insufﬁcient communication between
professional caregivers and a lack of guidelines after hospital
discharge. A common denominator might be insufﬁcient or non-
existent communication between hospital and home care
settings.24 Professional caregivers active in hospital and home
care might need to cooperate better and more often. By doing
this, one could adjust care and therapies more adequately and
better meet the patient’s wishes,34 while not forgetting to involve
the patients and their informal caregivers in discussion about care.
One option could be an electronic patient ﬁle accessible to the
patients, their informal caregivers, and the professional caregivers
in the hospital, the primary and the home care settings.35 This
electronic patient ﬁle could contain a classiﬁcation system that
emphasises patients’ (PHC) needs and functioning instead of the
disease, such as the comprehensive ICF core set for COPD,
developed by the World Health Organization.36 Another possibility
could be organizing multidisciplinary consultations consistently,
each time a serious deterioration of functioning occurs, similar to
multidisciplinary oncology consultations in Belgium. More
research is needed to explore whether these examples could
work for early integrated PHC in end-stage COPD.
Although it is known that PC and PHC increases quality of life
for people with end-stage COPD when integrated early,7 the
content of PHC needs adaptation if integrated before the terminal
stage, depending on the disease population and the personal
needs of the patient.37 Research has shown the need for
management of troublesome symptoms and short-term PC if
integrated early.6 Managing breathlessness or relieving psycho-
social symptoms which are often seen in end-stage COPD despite
receiving optimal medical care5 might require the involvement of
other care professionals besides a PHC nurse, such as a
physiotherapist, psychologist or social worker. Re-evaluating the
content of PHC if given early and integrated for end-stage COPD is
therefore necessary in order to be fully effective.
The large volume of results on professional caregiver-patient
communication showed plenty of room for improvement.
Participants claimed that some end-stage COPD patients did not
fully understand the disease, sometimes refused care and often
interpreted the term PC or PHC as a sign of impending death.
However, previous research found that patients with end-stage
COPD did express the desire to talk about end-of-life care30 and
fully accepted PHC and early integrated PHC.19 This could thus
mean that participants in our study either misinterpreted their
end-stage COPD patients’ wishes and communication preferences
about PHC, or that their end-stage COPD patients did not clearly
share their care needs which would conﬁrm other research ﬁnding
that patients often do not fully understand the severity of end-
stage COPD,38 or did not know what future care they would
prefer.22 In contrast, another study found that patients did convey
the need for involvement and education about end-stage COPD
and PC, which could improve PC communication.39 A previous
trial tested patient feedback by giving self-reported patient
questionnaires on end-of-life preferences for communication,
therapy and experiences. These were then given to the involved
professional caregivers which resulted in better patient-
professional caregiver communication.40 As literature and the
results of our study did not provide a clear answer to these
communication issues between professional caregivers and
patients, further testing of communication systems is suggested,
while improving undergraduate and postgraduate education for
professional caregivers on bad news delivery, ACP and shared
decision making.
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The unpredictable disease trajectory of end-stage COPD was
mentioned as a factor impeding (timely) referral to and
conversations about early integrated PHC, somewhat conﬁrmed
by research stating the need for clear identiﬁcation criteria for
pulmonologists to introduce PC in a timely manner.24 The trigger
points identiﬁed in the results of our study could respond to this
need, as they signal an increase in PHC needs due to a decline in
functioning of the end-stage COPD patient such as after a hospital
admission, a couple of exacerbations, oxygen-dependency or
becoming housebound. These trigger moments were not related
to life expectancy as the latter was seen as an inappropriate basis
for deciding whether early integrated PHC was needed, which is in
line with a study proving that criteria to predict survival in end-
stage COPD do not work.41 Moreover, at the time of the focus
group conversations, eligibility for PHC in Belgium was dependent
on a palliative status based on life expectancy (less than 3 months
before death), which was seen as a psychological barrier to early
integrating PHC as the unpredictability of COPD prevents
professional caregivers from deciding whether an end-stage
COPD-patient is likely to survive for three months. Nevertheless,
somewhat contrary to our results, a previous qualitative study with
end-stage COPD patients found that admission for exacerbation
was considered too chaotic and not an appropriate occasion to
discuss PC, although it could be a milestone leading to PC
discussions.31 Pulmonologists also stated that conversations about
treatment preferences should be initiated when an end-stage
COPD patient is stable.32 It is important to mention that the trigger
moments in the results of our study could give rise to an
opportunity for talking about early integrated PHC as these
moments could help the end-stage COPD patient realise the
severity of the disease, but initiating the conversations should take
place when the end-stage COPD patient is back in a stable
context, preferably at home, after the events had occurred. More
research is needed to explore the feasibility of addressing PHC
needs following the different triggers.
Strengths and limitations
The research team involved in data analysis were people with
different backgrounds including psychology, sociology, general
practice, primary care, PHC, pulmonology, and oncology. This
enhanced the interpretation of the data due to the multitude of
perspectives. Furthermore, to the extent of our knowledge, this is
the ﬁrst qualitative study reporting GPs’ and CNs’ insights into
barriers to and facilitators for early integration of PHC for people
with end-stage COPD. We obtained a varied sample of GPs and
CNs with different backgrounds, care experience and perspectives
on PHC. The high number (56) of participants in seven different
focus groups also constituted a key strength of this study as it
improved transferability of the ﬁndings beyond the context of the
individual participants’ experiences.
However, it is worth noting that due to altering recruitment
strategies at the start of the study not all participants reached the
inclusion criteria we predeﬁned for the study. Eleven out of 56 did
have less than ﬁve years working experience, and nine of 56
participants did not have COPD patients in their practice in the
past year. This could have inﬂuenced the results as professional
caregivers with less working experience or less experience with
COPD patients might have faced difﬁculties in answering
questions about early integration of PHC for end-stage COPD, as
they could have lacked the clinical experience to relate their
answers with. Nevertheless, we believe that due to the setting of a
focus group, where groups were formed with other participants
having many experience, this limitation did not compose any
substantial problems to the quality of the conversations and to the
results. During the focus group conversations, the experienced
professional caregivers inspired the less experienced participants
to reﬂect critically on the questions asked by the moderator. The
strength of the answers from focus group conversations also
relied on the vivid discussion between the participants who
challenged each other in giving answers to questions. Therefore,
we did not exclude the less experienced participants from the
analysis as their participation helped in obtaining the results.
Furthermore, 32 of 56 participants had never introduced end-
stage COPD patients to PC or PHC in the past year. This might
have affected the results due to a lack of experience with PC or
PHC for end-stage COPD between the participants. However, this
does not mean that the participants did not know what PC or PHC
can do for patients, as they had have experience with PC, but
mainly for cancer patients. Therefore, we believe that these
participants were able enough to form an opinion on why they
never or hardly introduce PHC for end-stage COPD patients
compared to cancer patients and what could be done to alter this.
Another limitation of this study was the lack of insights from
other professional caregivers involved in care for end-stage COPD
patients, such as pulmonologists and physiotherapists. Neither did
we consult patients with end-stage COPD or informal caregivers.
However, gaining insight into early integrated PHC was the
primary focus of the study and therefore we interviewed
professional caregivers active in primary and home care.
Notwithstanding these limitations, the results could provide
valuable information on the development of feasible interven-
tions, practical implementation and policy-related recommenda-
tions on early integrated PHC for end-stage COPD.
Implications for policy and practice, and future research
Given the complexity of implementing early integrated PHC for
end-stage COPD, we suggest a multilevel strategy approach in
order to successfully change related policy and practice.42 The
micro level could be adapted by increasing patients’ insight into
(end-stage) COPD and early integrated PHC using government-
funded campaigns about PC and PHC on national television which
could raise awareness of PC and PHC among the general
population. Meso-level changes could be on focusing professional
caregivers’ basic and continuing education more on clinical PHC
practice through obligatory internships in PC and PHC settings,
enhancing knowledge about (end-stage) COPD, PC and PHC
needs, advantages of early integrated PHC, and focusing on skills
in communication and ACP.
Finally, macro change by adapting the healthcare and PHC
system would be needed, for example by disconnecting eligibility
for palliative status and reimbursement of PHC-related costs from
life expectancy and instead linking it to lower functioning, PC and
PHC needs in end-stage COPD.27 Although the Flemish govern-
ment has decided to change this system, the law has not yet been
changed. Additionally, incorporating ACP as a standard procedure
within early integrated PHC to facilitate patient-professional
caregiver communication, and appointing care coordinators as
an additional role in existing care could provide continuous
support for end-stage COPD patients over different care settings.42
However this would require an economic costs and beneﬁts
analysis.
As this study was performed to develop the phase 2 EPIC trial,
the results suggested using a comprehensive PHC model in the
intervention with inclusion criteria representing high PHC needs
as a proxy to start early integrated PHC for end-stage COPD.43
Based on our results, these inclusion criteria representing high
PHC needs could be GOLD III or IV combined with low functioning
such as frequent hospitalisations for COPD, exacerbations due to
COPD, becoming housebound or oxygen-dependent. Key compo-
nents could cover several dimensions of appropriate PHC, from
improving patient’s disease insight, to training the PHC team in
knowledge and therapy for end-stage COPD, and integrating care
by trying to improve cooperation and communication between
involved professional caregivers. Previous interventions in early PC
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and PHC for end-stage COPD mainly focused on caring for one
symptom, for example managing breathlessness44 or provided
training about one care aspect, such as nutrition.23 Instead, we
suggest using several components to provide a holistic PHC
approach, in order to fully tackle the lack of early integrated PHC
for people with end-stage COPD.
CONCLUSION
Our study uncovered barriers in terms of the disease trajectory,
patient attitudes, professional caregivers’ practices, the healthcare
and PHC system and communication problems. Facilitators
provided possibilities at many levels for a successful implementa-
tion of early integrated PHC in practice or development of early
integrated PHC interventions for end-stage COPD. This requires a
multilevel approach with the involvement of professional
caregivers active in hospital and home settings, while not
forgetting to actively include end-stage COPD patients and
informal caregivers in the process.
METHODS
Study design
A qualitative approach using focus groups was chosen for its group
dynamic features that stimulate interaction between participants and allow
the moderator to use more active interview techniques than with face-to-
face interviews.45 This approach was supported by the methodological
orientation of grounded theory,45 as we constructed new insights based
on data obtained from the focus groups. The research protocol and topic
guides were approved by the Ethics Committee of Ghent University
Hospital (Reference: 2016/0171).
Study setting
The study was based in workplace settings in urban and semi-urban
regions in Flanders, Belgium, in 2016, as it was part of the development of
a phase 2 intervention on early integration of PHC for end-stage COPD in
Flanders, Belgium.
Study population and sampling
The study population consisted of GPs and CNs involved in primary and
home care settings. In selecting the participants, three criteria were
stipulated as a guiding line for recruitment: (1) Dutch speaking; (2) at least
ﬁve years experience as a GP or CN; (3) having cared for at least three end-
stage COPD patients. We also took into account variation in semi-urban
and urban areas. We then used ‘convenience sampling’. With this
technique, the sample was composed of participants or groups who met
the criteria and who were available or signed up ﬁrst.46 However,
individual recruitment of GPs and CNs for focus group participation was
difﬁcult and we had to change strategy. Only one focus group with CNs
was composed by gathering independent CNs from the same region. This
was done by contacting individual CNs from one urban area by phone
through a contact lis fron the Flemish Professional Association for
Independent Nurses which is available online: http://www.
verplegingthuis.be/.
As a solution, we used beside the convenience sampling technique, a
purposive sampling technique which allowed the research team to select
participants based on the researchers’ judgment. We organized focus
groups which consisted either of one regionally composed group of GPs or
one regionally composed group of CNs. This type of recruitment could
offer us a sample of GPs and CNs representing a wide range of experience
related to the topic (maximum variation sampling), even if not all
participants would meet the inclusion criteria. For GPs these were local
peer review GP groups (LOK): geographically determined groups of GPs
from both individual and group practices. They meet four times a year to
share and critically evaluate their medical practice (peer review) and to
improve their quality of care. For CNs these were regionally composed
groups from the National Association of Catholic Flemish Nurses and
Midwifes (NVKVV) who meet monthly to discuss their practice and share
work-related experiences.47
Recruitment strategy
The participants were initially identiﬁed by a member of the research team
and other key contacts who were either a GP, CN, or policy member of
organisations involved in community care. Further recruitment for GPs was
undertaken by contacting several people responsible for local peer review
(LOK) GP groups in Flanders in person, by phone or e-mail. Further
recruitment of CNs were recruited by contacting the “Wit-Gele Kruis”, a
Flemish organisation for CNs. This organisation was asked to help with the
recruitment by forwarding the call for participants to its members. With the
help of this organisation, we contacted those responsible for regionally
composed groups of CNs by phone to organise the focus group when that
group had a meeting. Potential groups of GPs or CNs were invited to take
part in a focus group with e-mails containing information about the study
and participation. Suitable dates and venues were arranged with the people
in charge of the local peer review GP groups or regionally composed CN
group, if all group members agreed to participate in the study.
Data collection
Recruitment and focus group conversations took place between March
and September 2016. A semi-structured topic guide (pilot tested),
consisting of four main questions and a set of prompts for each question,
was developed and reviewed within a multidisciplinary research team of
sociologists, a GP, a lung specialist and an oncologist (for content of the
topic guide: Fig. 1). End-stage COPD was described during the focus group
as mostly GOLD stage III or IV3 and low to very low functioning’.
Introducon
1. What are the main problems for people with end-stage COPD, physically, psychologically and socially? 
- Which problems of people with end-stage COPD have the biggest impact on their well-being and 
health? 
2. How is the current palliave home care for people with end-stage COPD organised?
- Who is involved in the current care and what are their roles?
- What is the quality level of communicaon and informaon towards people with end-stage COPD? 
3. How could the current problems with PHC for people with end-stage COPD be beer addressed (through 
involvement of palliave home care teams)?
- How could some soluons help improve quality of life for people with end-stage COPD?
- Which professional caregiver could play a role in the improvement?
4. How could early integraon of palliave home care be implemented in standard care for people with end-
stage COPD? 
Fig. 1 Topic list based on research questions
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Each focus group was moderated by one male senior researcher
(sociologist or psychologist) and observed by one female junior researcher
(sociologist or psychologist) who made ﬁeld notes, all experienced in
conducting focus groups due to training in former education and
conducting qualitative research in previous studies. The focus groups took
place in a quiet room, were conducted in Flemish, lasted on average one
and a half hours and were audio taped, for which all participants gave
informed written consent. All participants ﬁlled in a short questionnaire
regarding their own demographic characteristics, clinical experience and
experience with care and PC or PHC for end-stage COPD. After conducting
two focus groups with GPs, the research team slightly adapted the topic list
by leaving out the ﬁrst question on perceived main problems for people
with end-stage COPD, as this question did not lead to signiﬁcant information
regarding early integrated PHC. We continued recruitment and sampling
until data saturation was achieved. Saturation was deﬁned when no new
themes on barriers and facilitators occurred during the focus group.
Data analysis
The focus groups were completely transcribed verbatim. Then we used NVivo
9 software to code and analyse the data according to the research questions.
Two researchers (CS and KC) ﬁrst read and coded the data in themes which
were derived from the data from four full focus group transcripts and
compared similarities and differences in their analyses until a primary coding
framework was constructed. Then all seven focus group transcripts were
independently read, compared with the primary coding framework by the
two researchers and these results were discussed with all members of the
research team. Codes were added, modiﬁed or merged when necessary. A
third and fourth researcher (PP and LD) made ﬁnal changes to the codes,
which were approved by the other two coding researchers. Once coding was
ﬁnalized, all transcripts and the coding framework were revised and reﬁned,
resulting in (sub)categories of barriers and facilitators. Quotations were
selected and approved by the research team to illustrate the results.
Transcripts were not sent back to participants for correction but respondent
validation of the results was undertaken by sending the results of the study
by e-mail to all participating GPs and CNs for consent.
Data availability
The data that support the ﬁndings of this study are available from the
corresponding author (C.S) upon reasonable request.
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